IBRX (ImmunityBio Corp) Wutah pendapatan kuartal marang kuartal

Tandha merek immunitybio.com (IBRX)

ImmunityBio, Inc. (IBRX) scalability is based on an adaptive vaccine platform that reduces development costs. The quarterly growth in commercial revenue, as reflected in GURU.Markets quotes, confirms asset growth, while 52.80 reflects the latest metric value. Prospects are tied to the market launch of Anktiva and expansion into new NK-cell niches, which expands the customer base due to high demand.

NantKwest (IBRX) - Owah-owahan pendapatan dibandhingake kuartal kepungkur saka 04.07.2022 nganti 19.11.2026

Rincian analitis perusahaan ImmunityBio (IBRX)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:IBRX - ImmunityBio, Inc.
Produk sing diprodhuksi immunitybio.com

Monitoring operational efficiency through sales growth rates is key for fundamental asset screening. By analyzing quarterly revenue trends, an investor assesses the percentage change in income over a period, which is critical for ImmunityBio, Inc. (IBRX), as the commercialization of Anktiva and the protection of NK platforms create high barriers to entry, determining the future capitalization of the biopharmaceutical ecosystem.

Perusahaan pesaing

IMCR - Wutah pendapatan kuartal marang kuartal|JANX (januxrx.com) - Wutah dodolan kuartal marang kuartal|Arcus Corp (RCUS) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Zymeworks Corp (ZYME)|Wutah dodolan triwulanan TNGX|IOVA - Owah-owahan pendapatan dibandhingake kuartal kepungkur|Wutah dodolan triwulanan IMTX (Immatics Corp)|Owah-owahan dodolan kuartal marang kuartal XNCR|Wutah pendapatan triwulanan CMPX (Compass Therapeutics, Inc.)|Tambahing pendapatan triwulanan REPL|lyell.com - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Innate Pharma S.A|Pyxis (PYXS) - Wutah pendapatan kuartal marang kuartal|Compugen Ltd - Tambahing pendapatan triwulanan|IOBT (iobiotech.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Sutro Biopharma Inc.|Wutah pendapatan kuartal marang kuartal MiNK Therapeutics (INKT)|HOWL: Dinamika pendapatan kuartal marang kuartal|Immix Biopharma - Wutah dodolan triwulanan|ALX Oncology (ALXO) - Tingkat wutah pendapatan sajrone kuartal|CUE: Wutah dodolan triwulanan|Dinamika pendapatan kuartal marang kuartal PDSB|sonnetbio.com (SONN) - Wutah pendapatan kuartal marang kuartal|MAIA Biotechnology Inc (MAIA) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal liminatuspharma.com|Wutah pendapatan kuartal marang kuartal LVTX|Wutah dodolan triwulanan NXTC (NextCure, Inc.)|LPTX: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Tingkat wutah pendapatan sajrone kuartal|TOVX: Wutah dodolan triwulanan|Gritstone bio - Owah-owahan dodolan kuartal marang kuartal|Kineta Bio (KA) - Wutah pendapatan kuartal marang kuartal|NexImmune Inc (NEXI) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Turnstone Biologics Corp.|Wutah dodolan kuartal marang kuartal VCNX (Vaccinex, Inc.)|Wutah dodolan triwulanan HARP (Harpoon Tx)